Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor
Clinical trial NCT03932864 · COMPLETED
Trial details
- NCT number
- NCT03932864
- Sponsor
- Ensoma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2020-02-25
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.